Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients.
Front Immunol. 2023 May 22;14:1188030. doi: 10.3389/fimmu.2023.1188030. eCollection 2023.
Front Immunol. 2023.
PMID: 37283737
Free PMC article.
Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapse.
Hoffmann O, Wormland S, Bittner AK, Collenburg M, Horn PA, Kimmig R, Kasimir-Bauer S, Rebmann V.
Hoffmann O, et al. Among authors: wormland s.
J Cancer Res Clin Oncol. 2023 Mar;149(3):1159-1174. doi: 10.1007/s00432-022-03980-9. Epub 2022 Apr 2.
J Cancer Res Clin Oncol. 2023.
PMID: 35366112
Free PMC article.
Item in Clipboard
Cite
Cite